TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Fusion Pharm Inc (OTCMKTS:FSPM) Investor Investigation Concerning Potential Securities Laws Violations Announced

  • If you purchased shares of Fusion Pharm Inc (OTCMKTS:FSPM), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Fusion Pharm Inc
Security
OTCMKTS: FSPM

Summary

October 7, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Fusion Pharm Inc (OTCMKTS:FSPM) shares over potential securities laws violations by Fusion Pharm Inc and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Fusion Pharm Inc (OTCMKTS:FSPM) concerning whether a series of statements by Fusion Pharm Inc (OTCMKTS:FSPM regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On September 16, 2016, the Securities and Exchange Commission (SEC) announced fraud charges against Fusion Pharm Inc and its CEO, Scott M. Dittman, among others, for allegedly misleading investors by recording and trumpeting revenues for purported sales of PharmPods by round-tripping money from illegal stock sales by hidden affiliates.

Shares of Fusion Pharm Inc (OTCMKTS:FSPM) closed on October 7, 2016, at $0.0002 per share.

Start Monitoring Your Investments